top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Quantitative decisions in drug development / / Christy Chuang-Stein, Simon Kirby
Quantitative decisions in drug development / / Christy Chuang-Stein, Simon Kirby
Autore Chuang-Stein Christy
Edizione [Second edition.]
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2021]
Descrizione fisica 1 online resource (354 pages)
Disciplina 615.19
Collana Springer Series in Pharmaceutical Statistics
Soggetto topico Drug development - Decision making
Drug development - Economic aspects
Desenvolupament de medicaments
Presa de decisions
Soggetto genere / forma Llibres electrònics
ISBN 3-030-79731-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNISA-996466409503316
Chuang-Stein Christy  
Cham, Switzerland : , : Springer, , [2021]
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Quantitative Decisions in Drug Development / / by Christy Chuang-Stein, Simon Kirby
Quantitative Decisions in Drug Development / / by Christy Chuang-Stein, Simon Kirby
Autore Chuang-Stein Christy
Edizione [2nd ed. 2021.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (354 pages)
Disciplina 615.19
Collana Springer Series in Pharmaceutical Statistics
Soggetto topico Statistics
Biometry
Sampling (Statistics)
Pharmacology
Statistical Theory and Methods
Biostatistics
Methodology of Data Collection and Processing
ISBN 9783030797317
3030797317
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1 - Clinical Testing of a New Drug -- Chapter 2 - A Frequentist Decision-making Framework -- Chapter 3 - Characteristics of a Diagnostic Test -- Chapter 4 - The Parallel Between Clinical Trials and Diagnostic Tests -- Chapter 5 - Incorporating Information from Completed Trials in Future Trial Planning -- Chapter 6 - Choosing Metrics Appropriate for Different Stages of Drug Development -- Chapter 7 - Designing Proof-of-Concept Trials with Desired Characteristics -- Chapter 8 - Designing Dose-response Studies with Desired Characteristics -- Chapter 9 - Designing Confirmatory Trials with Desired Characteristics -- Chapter 10 - Designing Phase 4 Trials -- Chapter 11 - Other Metrics That Have Been Proposed to Optimize Drug Development Decisions -- Chapter 12 - Discounting Prior Results to Account for Selection Bias -- Chapter 13 - Adaptive Designs -- Chapter 14 - Additional Topics.
Record Nr. UNINA-9910497090203321
Chuang-Stein Christy  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Quantitative Decisions in Drug Development / / by Christy Chuang-Stein, Simon Kirby
Quantitative Decisions in Drug Development / / by Christy Chuang-Stein, Simon Kirby
Autore Chuang-Stein Christy
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (XV, 248 p. 27 illus., 11 illus. in color.)
Disciplina 519.5
Collana Springer Series in Pharmaceutical Statistics
Soggetto topico Statistics
Biometry
Pharmacy
Pharmaceutical technology
Quality control
Reliability
Industrial safety
Statistics for Life Sciences, Medicine, Health Sciences
Biostatistics
Drug Safety and Pharmacovigilance
Pharmaceutical Sciences/Technology
Quality Control, Reliability, Safety and Risk
ISBN 3-319-46076-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Clinical Testing of a New Drug -- A Frequentist Decision-making Framework -- Characteristics of a Diagnostic Test -- The Parallel Between Clinical Trials and Diagnostic Tests -- Incorporating Information from Completed Trials in Future Trial Planning -- Choosing Metrics Appropriate for Different Stages of Drug Development -- Designing Proof-of-Concept Trials with Desired Characteristics -- Designing Dose-response Studies with Desired Characteristics -- Designing Confirmatory Trials with Desired Characteristics -- Designing Phase 4 Trials -- Other Metrics That Have Been Proposed to Optimize Drug Development Decisions -- Discounting Prior Results to Account for Selection Bias -- Index -- Appendix.
Record Nr. UNINA-9910254282103321
Chuang-Stein Christy  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui